Alexander Nowak
Stock Analyst at Craig-Hallum
(2.78)
# 1,824
Out of 5,162 analysts
47
Total ratings
47.37%
Success rate
7.16%
Average return
Main Sectors:
Stocks Rated by Alexander Nowak
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BVS Bioventus | Maintains: Buy | $15 → $16 | $8.62 | +85.61% | 7 | Mar 6, 2026 | |
| CELC Celcuity | Maintains: Buy | $96 → $108 | $114.22 | -5.45% | 3 | Nov 13, 2025 | |
| CVRX CVRx, Inc. | Maintains: Buy | $20 → $22 | $7.53 | +192.16% | 5 | Jan 17, 2025 | |
| NTRA Natera | Maintains: Buy | $121 → $157 | $187.85 | -16.42% | 4 | Nov 13, 2024 | |
| QDEL QuidelOrtho | Upgrades: Buy | $40 → $57 | $17.10 | +233.33% | 6 | Sep 5, 2024 | |
| CDNA CareDx | Upgrades: Buy | $12 → $15 | $17.01 | -11.82% | 3 | May 1, 2024 | |
| DMAC DiaMedica Therapeutics | Assumes: Buy | $8 | $7.28 | +9.89% | 4 | Apr 24, 2024 | |
| LUNG Pulmonx | Initiates: Buy | $18 | $1.68 | +971.43% | 1 | Sep 5, 2023 | |
| TNDM Tandem Diabetes Care | Maintains: Buy | $74 → $50 | $21.59 | +131.59% | 2 | Jun 13, 2023 | |
| DRIO DarioHealth | Maintains: Buy | $280 → $160 | $9.00 | +1,677.78% | 1 | May 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $103.57 | - | 1 | Oct 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $0.75 | - | 2 | Mar 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $11 | $1.89 | +482.01% | 1 | Jan 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $88 → $110 | $50.85 | +116.32% | 3 | Feb 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sell | n/a | $5.64 | - | 2 | Jan 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $300 | $1.24 | +24,093.55% | 1 | Jan 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $28 | $9.31 | +200.75% | 1 | Aug 31, 2020 |
Bioventus
Mar 6, 2026
Maintains: Buy
Price Target: $15 → $16
Current: $8.62
Upside: +85.61%
Celcuity
Nov 13, 2025
Maintains: Buy
Price Target: $96 → $108
Current: $114.22
Upside: -5.45%
CVRx, Inc.
Jan 17, 2025
Maintains: Buy
Price Target: $20 → $22
Current: $7.53
Upside: +192.16%
Natera
Nov 13, 2024
Maintains: Buy
Price Target: $121 → $157
Current: $187.85
Upside: -16.42%
QuidelOrtho
Sep 5, 2024
Upgrades: Buy
Price Target: $40 → $57
Current: $17.10
Upside: +233.33%
CareDx
May 1, 2024
Upgrades: Buy
Price Target: $12 → $15
Current: $17.01
Upside: -11.82%
DiaMedica Therapeutics
Apr 24, 2024
Assumes: Buy
Price Target: $8
Current: $7.28
Upside: +9.89%
Pulmonx
Sep 5, 2023
Initiates: Buy
Price Target: $18
Current: $1.68
Upside: +971.43%
Tandem Diabetes Care
Jun 13, 2023
Maintains: Buy
Price Target: $74 → $50
Current: $21.59
Upside: +131.59%
DarioHealth
May 12, 2023
Maintains: Buy
Price Target: $280 → $160
Current: $9.00
Upside: +1,677.78%
Oct 19, 2022
Downgrades: Hold
Price Target: n/a
Current: $103.57
Upside: -
Mar 28, 2022
Downgrades: Hold
Price Target: n/a
Current: $0.75
Upside: -
Jan 5, 2022
Initiates: Buy
Price Target: $11
Current: $1.89
Upside: +482.01%
Feb 3, 2021
Maintains: Buy
Price Target: $88 → $110
Current: $50.85
Upside: +116.32%
Jan 20, 2021
Downgrades: Sell
Price Target: n/a
Current: $5.64
Upside: -
Jan 11, 2021
Initiates: Buy
Price Target: $300
Current: $1.24
Upside: +24,093.55%
Aug 31, 2020
Initiates: Buy
Price Target: $28
Current: $9.31
Upside: +200.75%